======= CFHR5 =======
== Gene Information ==
* **Official Symbol**: CFHR5
* **Official Name**: complement factor H related 5
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=81494|81494]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9BXR6|Q9BXR6]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=CFHR5&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20CFHR5|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/608593|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene is a member of a small complement factor H (CFH) gene cluster on chromosome 1. Each member of this gene family contains multiple short consensus repeats (SCRs) typical of regulators of complement activation. The protein encoded by this gene has nine SCRs with the first two repeats having heparin binding properties, a region within repeats 5-7 having heparin binding and C reactive protein binding properties, and the C-terminal repeats being similar to a complement component 3 b (C3b) binding domain. This protein co-localizes with C3, binds C3b in a dose-dependent manner, and is recruited to tissues damaged by C-reactive protein. Allelic variations in this gene have been associated, but not causally linked, with two different forms of kidney disease: membranoproliferative glomerulonephritis type II (MPGNII) and hemolytic uraemic syndrome (HUS). [provided by RefSeq, Jan 2010].
* **UniProt Summary**: Involved in complement regulation. The dimerized forms have avidity for tissue-bound complement fragments and efficiently compete with the physiological complement inhibitor CFH. {ECO:0000269|PubMed:23487775}.
|Sushi|
|positive regulation of cytolysis|
|complement activation, alternative pathway|
|regulation of cytolysis|
|negative regulation of protein binding|
|regulation of complement activation|
|regulation of humoral immune response|
|negative regulation of binding|
|complement activation|
|regulation of protein binding|
|humoral immune response|
|regulation of binding|
|regulation of immune effector process|
|protein heterodimerization activity|
|protein-containing complex|
|activation of immune response|
|innate immune response|
|positive regulation of immune response|
|protein homodimerization activity|
|defense response to other organism|
|immune effector process|
|negative regulation of molecular function|
|regulation of immune response|
|positive regulation of immune system process|
|response to other organism|
|response to external biotic stimulus|
|response to biotic stimulus|
|defense response|
|regulation of immune system process|
|immune response|
|extracellular region|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp400|Senexin-A 25μM R07 exp400]]|-1.77|
|[[:results:exp365|I-BRD9 4μM R07 exp365]]|-1.71|
|[[:results:exp494|Isoniazid 100μM R08 exp494]]|2.25|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 19043
* **Expression level (log2 read counts)**: -3.42
{{:chemogenomics:nalm6 dist.png?nolink |}}